Recommendations for the management of cardiovascular risk in patients with chronic myeloid leukemia on tyrosine kinase inhibitors: risk assessment, stratification, treatment and monitoring.
Hematol Transfus Cell Ther
; 43(2): 191-200, 2021.
Article
en En
| MEDLINE
| ID: mdl-32631809
Texto completo:
1
Colección:
01-internacional
Base de datos:
MEDLINE
Tipo de estudio:
Etiology_studies
/
Guideline
/
Prognostic_studies
/
Risk_factors_studies
Idioma:
En
Revista:
Hematol Transfus Cell Ther
Año:
2021
Tipo del documento:
Article
Pais de publicación:
Brasil